文献速递临床试验与 GCP真实世界研究与卫生经济

系列:实用性试验与真实世界证据:第1篇 引言

Series: Pragmatic trials and real world evidence: Paper 1. Introduction.
PubMed 文献 · J Clin Epidemiol · 2017-05-24

本文是八篇系列文章的引言,阐述实用性试验的设计理念,即将理论设计选项与实施实用性试验的实践相结合。实用性试验可在常规临床实践中提供治疗策略的相对有效性证据,同时保持随机对照试验的强度,但设计时需权衡可行性、利益相关者接受度、有效性、精确度和可推广性。

要点

  • 实用性试验可在常规临床实践中评估治疗策略的相对有效性,填补临床证据不足。
  • 设计实用性试验需选择设置、研究人群、干预方式、对照和结局等关键要素。
  • 需权衡实用性设计选项、可行性、利益相关者接受度、有效性、精确度和可推广性。

核心结论

  • 本文介绍实用性试验设计的概念,阐明实用性设计选项、可行性、利益相关者接受度、有效性、精确度和可推广性之间的复杂相互作用,以便在实用性试验中做出平衡的设计选择,从而在实践中获得最佳成功机会。

研究设计与样本

  • 本文为八篇系列文章的引言,整合实用性试验的理论设计选项与实施实践。

主要发现

  • 对于大多数新获批上市的治疗,临床证据不足以完全指导医生和政策制定者为患者选择最佳治疗。
  • 实用性试验可在常规临床实践中提供治疗策略相对有效性的证据,并可在开发的早期阶段进行,同时保持随机对照试验的强度。
  • 选择设置、研究人群、干预方式、对照和结局是设计实用性试验的关键。
  • 结合不改变常规护理的监测和数据收集,可将结果适当推广至临床实践中的目标患者群体。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This is the introductory paper in a series of eight papers. In this series, we integrate the theoretical design options with the practice of conducting pragmatic trials. For most new market-approved treatments, the clinical evidence is insufficient to fully guide physicians and policy makers in choosing the optimal treatment for their patients. Pragmatic trials can fill this gap, by providing evidence on the relative effectiveness of a treatment strategy in routine clinical practice, already in an early phase of development, while maintaining the strength of randomized controlled trials. Selecting the setting, study population, mode of intervention, comparator, and outcome are crucial in designing pragmatic trials. In combination with monitoring and data collection that does not change routine care, this will enable appropriate generalization to the target patient group in clinical practice. To benefit from the full potential of pragmatic trials, there is a need for guidance and tools in designing these studies while ensuring operational feasibility. This paper introduces the concept of pragmatic trial design. The complex interplay between pragmatic design options, feasibility, stakeholder acceptability, validity, precision, and generalizability will be clarified. In this way, balanced design choices can be made in pragmatic trials with an optimal chance of success in practice.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Zuidgeest MGP, Goetz I, Groenwold RHH, et al. Series: Pragmatic trials and real world evidence: Paper 1. Introduction. J Clin Epidemiol. 2017. PMID: 28549929. doi:10.1016/j.jclinepi.2016.12.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。